Delivery Order SPE2DB25D3504-SPE2DB25FVVAC

Award Date 6/6/25
Potential Completion Date 6/9/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,297.48 firm-fixed-price contract is for the delivery of KERENDIA 10 MG TABLET 30S, a pharmaceutical product. The contract has a performance period extending through May 28, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,575.16 firm fixed price delivery order is for the supply of KERENDIA 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of May 23, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,536.04 firm fixed-price delivery order is for the supply of KERENDIA 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,663.43 firm-fixed-price contract is for the delivery of the medication KERENDIA 10 MG TABLET 30S, with a completion date of May 21, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX. This prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,997.56 Firm Fixed Price delivery order contract is for the provision of the pharmaceutical product KERENDIA 20 MG TABLET 30S. The contract has an ultimate completion date of May 21, 2024. Amerisourcebergen holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price, valued at $1,351.74, to provide the medication "KERENDIA 10 MG TABLET 30S" to support military healthcare programs. The contract has an ultimate completion date of April 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,970.95, is for the delivery of Kerendia 10 mg tablets. The contract has an ultimate completion date of November 13, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,652.68 firm fixed-price contract is for the supply of KERENDIA 20 MG TABLET 30S, a medical product, with a performance period ending on June 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for providing a comprehensive range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order valued at $10,031.31 for the medication KERENDIA 10 MG TABLET 30S. The contract has a completion date of June 10, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,757.31 firm fixed-price delivery order is for the supply of KERENDIA 10 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of May 20, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB25D3504
    Indefinite Delivery Contract
  • SPE2DB25D3504-SPE2DB25FVVAC
    Delivery Order

This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,815.70 firm-fixed-price contract is for the delivery of the pharmaceutical product KERENDIA 10 MG TABLET 30S. The contract has a completion date of June 9, 2025.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.

The contract award is not designated as a set-aside, indicating open competition. As a large, established pharmaceutical distributor, Amerisourcebergen Drug Corp is well-positioned to fulfill diverse federal medical supply requirements through its prime contracts and delivery orders with the DLA.

Generated 9/5/25, 10:00 AM